Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Asthma

Free Subscription Articles published in Ann Allergy Asthma Immunol Retrieve available abstracts of 254 articles: HTML format

Single Articles

May 2024
1. KLOEPFER KM, Kennedy JL
   Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
   Ann Allergy Asthma Immunol. 2024;132:553-554.
   PubMed    
   
   
   
2. KATIAL RK, Hoyte FCL
   Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
   Ann Allergy Asthma Immunol. 2024;132:551-552.
   PubMed    
   
   
   April 2024
3. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
   The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
   Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
   PubMed     Abstract available
   
   
   
4. WOO SD, Park HS, Yang EM, Ban GY, et al
   8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
   Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
   PubMed     Abstract available
   
   
   March 2024
5. MOTA D, Martins C, Puga N, Moreira A, et al
   Asthma and allergy screening in elite football athletes: is it worth it?
   Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
   PubMed    
   
   
   
6. LEE PH, An M, Hwang D, Jang AS, et al
   Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
   Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
   PubMed    
   
   
   
7. HUANG D, Zhang L, Liu Y, Wang J, et al
   Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
   Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
   PubMed     Abstract available
   
   
   
8. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
   Evidence for two clusters among non-eosinophilic asthmatics.
   Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
   PubMed     Abstract available
   
   
   
9. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
   Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
   Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
   PubMed     Abstract available
   
   
   
10. LI Y, Hong X, Chandran A, Keet CA, et al
    Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
    Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
    PubMed     Abstract available
    
    
    
11. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
    Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
    Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
    PubMed     Abstract available
    
    
    February 2024
12. CETIN GP, Yilmaz I
    What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
    Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
    PubMed    
    
    
    
13. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
    PubMed    
    
    
    
14. YAO Y, Yang Y, Wang J, Yu P, et al
    Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 19:S1081-1206(24)00084.
    PubMed     Abstract available
    
    
    
15. NGO SY, Bothwell S, Brinton JT, Anderson WC 3rd, et al
    Preparing Adolescents for Independent Asthma Management: Gaps and Opportunities.
    Ann Allergy Asthma Immunol. 2024 Feb 17:S1081-1206(24)00086.
    PubMed    
    
    
    
16. MCCANN W, Murphy KR, Zeiger RS, Beuther DA, et al
    Assessing Meaningful Change in the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Feb 16:S1081-1206(24)00085.
    PubMed     Abstract available
    
    
    
17. AKAMATSU T, Shirai T, Okawa K, Hirai K, et al
    Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor alpha.
    Ann Allergy Asthma Immunol. 2024 Feb 13:S1081-1206(24)00080.
    PubMed    
    
    
    
18. HAN YY, Rosser F, Acosta-Perez E, Canino G, et al
    Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Feb 5:S1081-1206(24)00075.
    PubMed    
    
    
    January 2024
19. BRACKEN AC, Oppenheimer JJ, Mosnaim GS, Rank MA, et al
    Simplifying asthma management in a university setting: a perspective.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00014.
    PubMed    
    
    
    
20. ZHOU X, Sampath V, Nadeau KC
    Effect of Air Pollution on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00018.
    PubMed     Abstract available
    
    
    
21. CHEN C, Song X, Murdock DJ, Marcus A, et al
    Association between allergic conditions and COVID-19 susceptibility and outcomes.
    Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
    PubMed     Abstract available
    
    
    
22. ROSAS-SALAZAR C, Bacharier LB
    The biologic asthma response score: A blueprint to address biologic failure in severe asthma?
    Ann Allergy Asthma Immunol. 2024;132:7-8.
    PubMed    
    
    
    
23. SHAKER M, Golden DBK
    More than 80 years of excellence and collaboration in allergy ... and just getting started.
    Ann Allergy Asthma Immunol. 2024;132:3-4.
    PubMed    
    
    
    
24. LIEBERMAN JA
    Trials and tribulations of managing pediatric and adolescent asthma.
    Ann Allergy Asthma Immunol. 2024;132:1-2.
    PubMed    
    
    
    December 2023
25. AKEL MJ, Camargo CA Jr, Fujiogi M, Hasegawa K, et al
    Lack of health disparities during implementation of hospital-initiated care bundle among hospitalized adults with asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01514.
    PubMed    
    
    
    
26. PEREZ-DE-LLANO L, Scelo G, Canonica GW, Chen W, et al
    Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01508.
    PubMed     Abstract available
    
    
    
27. CAMARGO CA JR, Rane PB, Beck AF, Wang Y, et al
    Geographic Variation in Disease Burden Among Patients with Severe Persistent Asthma in the United States.
    Ann Allergy Asthma Immunol. 2023 Dec 21:S1081-1206(23)01501.
    PubMed     Abstract available
    
    
    
28. MOHAN A, Desai B, Lugogo N
    Analyzing Co-morbidities and their Influence on Severe Asthma: Another Missing Piece of the Puzzle Solved?
    Ann Allergy Asthma Immunol. 2023 Dec 20:S1081-1206(23)01500.
    PubMed    
    
    
    
29. ADGENT MA, Buth E, Norona-Zhou A, Szpiro AA, et al
    Maternal stressful life events during pregnancy and childhood asthma and wheeze.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01498.
    PubMed     Abstract available
    
    
    
30. CHU DK, Schneider L, Asiniwasis RN, Boguniewicz M, et al
    Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01455.
    PubMed     Abstract available
    
    
    
31. ANAGNOSTOU A, Greenhawt M, Shaker M
    Improving Food Allergy Management: Control Asthma and Decrease Food Allergy Risk.
    Ann Allergy Asthma Immunol. 2023 Dec 12:S1081-1206(23)01495.
    PubMed    
    
    
    
32. STEPPE S, Stokes DC, Underhill C, Winders TA, et al
    Changing High-Risk Asthma in Memphis Through Partnership: Results from the CHAMP Program.
    Ann Allergy Asthma Immunol. 2023 Dec 9:S1081-1206(23)01486.
    PubMed     Abstract available
    
    
    
33. SIRCAR K, Hagen MB, Prezzato E, Hsu J, et al
    Opportunities to monitor disparities in asthma and other respiratory diseases using public health data.
    Ann Allergy Asthma Immunol. 2023;131:683-684.
    PubMed    
    
    
    
34. GRAYSON MH
    Congratulations to the 2023 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2023;131:681-682.
    PubMed    
    
    
    November 2023
35. PETERS AT, Sagara H, Corren J, Domingo C, et al
    Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma.
    Ann Allergy Asthma Immunol. 2023 Nov 25:S1081-1206(23)01470.
    PubMed     Abstract available
    
    
    
36. SHERENIAN M, Biagini JM, Ryan P, Hershey GKK, et al
    What allergist/immunologists can do to limit the effects of air pollution on asthma and allergies.
    Ann Allergy Asthma Immunol. 2023 Nov 24:S1081-1206(23)01468.
    PubMed    
    
    
    
37. YANG Y, Kimura H, Yokota I, Makita H, et al
    Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01464.
    PubMed     Abstract available
    
    
    
38. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
    Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
    PubMed     Abstract available
    
    
    
39. COREY KB, Moore R, Zuckerman AD, Littlejohn M, et al
    Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2023 Nov 17:S1081-1206(23)01454.
    PubMed    
    
    
    
40. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 Nov 15:S1081-1206(23)01402.
    PubMed     Abstract available
    
    
    
41. BLAISS M, Bleecker ER, Jacob-Nara J, Nair R, et al
    Real-world effectiveness of dupilumab in patients with asthma: findings from the United States ADVANTAGE study.
    Ann Allergy Asthma Immunol. 2023 Nov 13:S1081-1206(23)01399.
    PubMed     Abstract available
    
    
    
42. AGARWAL CD, Palka JM, Gajewski AJ, Khan DA, et al
    The Efficacy of Citalopram or Escitalopram in Patients with Asthma and Major Depressive Disorder.
    Ann Allergy Asthma Immunol. 2023 Nov 10:S1081-1206(23)01401.
    PubMed     Abstract available
    
    
    
43. GEVAERT P, Mullol J, Saenz R, Ko J, et al
    Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
    PubMed     Abstract available
    
    
    
44. CHEN M, Bacong AM, Feng C, Kikuta NT, et al
    Asthma heterogeneity amongst Asian American children: the California Health Interview Survey.
    Ann Allergy Asthma Immunol. 2023 Nov 8:S1081-1206(23)01395.
    PubMed     Abstract available
    
    
    
45. XU J, Rathkopf MM
    The cost of medication costs: Cost-related medication nonadherence in patients with asthma in the United States.
    Ann Allergy Asthma Immunol. 2023;131:538-539.
    PubMed    
    
    
    October 2023
46. PATEL D, Revier MD, Tambay A, Geng B, et al
    Implementation of a Pediatric Synchronous Multidisciplinary Severe Asthma Clinic and Real-World Outcomes.
    Ann Allergy Asthma Immunol. 2023 Oct 26:S1081-1206(23)01380.
    PubMed    
    
    
    
47. HO JK, Shaker M, Greenhawt M, Sadatsafavi M, et al
    Cost-effectiveness of budesonide-formoterol versus inhaled epinephrine in United States adults with mild asthma.
    Ann Allergy Asthma Immunol. 2023 Oct 23:S1081-1206(23)01352.
    PubMed     Abstract available
    
    
    
48. JOHNSON KM, Cheng L, Yin Y, Carter R, et al
    Impact of income-based public drug coverage deductibles on adherence to asthma medications.
    Ann Allergy Asthma Immunol. 2023 Oct 21:S1081-1206(23)01345.
    PubMed     Abstract available
    
    
    
49. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
    Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection.
    Ann Allergy Asthma Immunol. 2023 Oct 18:S1081-1206(23)01342.
    PubMed    
    
    
    
50. KILPATRICK K, Ambrose CS, Lindsley AW, Oppenheimer J, et al
    At-Home Asthma Mortality Unchanged Despite Declining Mortality in Other Settings: US Death Certificate Data (2000-2019).
    Ann Allergy Asthma Immunol. 2023 Oct 15:S1081-1206(23)01315.
    PubMed     Abstract available
    
    
    
51. CHAN R, Lipworth B
    Characterising moderate-to-severe asthma patients with preserved small airway function.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01306.
    PubMed    
    
    
    
52. AVERILL SH, Forno E
    Management of the Pediatric Patient with Asthma and Obesity.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01301.
    PubMed     Abstract available
    
    
    
53. SHAKER M, Abrams EM, Sublett JW
    Corrigendum to "Contextual community epinephrine prescribing: Is more always better?" [Ann Allergy Asthma Immunol 131 (2023) 176-184].
    Ann Allergy Asthma Immunol. 2023;131:534.
    PubMed    
    
    
    
54. COSCIA G
    Asthma control questionnaires: A broader perspective.
    Ann Allergy Asthma Immunol. 2023;131:405-406.
    PubMed    
    
    
    
55. HERZBERG SD, Bosso AM, Sangal NR, Bosso JV, et al
    Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:528-530.
    PubMed    
    
    
    September 2023
56. BLAISS M, Oppenheimer J, Corbett M, Bacharier L, et al
    Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment.
    Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218.
    PubMed    
    
    
    
57. GRAYSON MH, Williams PV
    Defining remission in asthma care.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217.
    PubMed    
    
    
    
58. HUNT KM, Foley M, Connors LA, Hildebrand KJ, et al
    Trends in the Proportion of Women Speakers at North American Allergy & Immunology Conferences, 2008-2020.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01215.
    PubMed     Abstract available
    
    
    
59. KIM SL, Rank MA, Peters AT
    The chronic rhinosinusitis practice parameter.
    Ann Allergy Asthma Immunol. 2023;131:307-310.
    PubMed     Abstract available
    
    
    
60. SUPRON AD, Bergmark RW, Roditi RE, Buchheit KM, et al
    Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.
    Ann Allergy Asthma Immunol. 2023;131:384-386.
    PubMed    
    
    
    
61. RAMOS CL, Thakrar H, Walters K, Waldram J, et al
    Characterization of alcohol-induced respiratory symptoms in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:382-384.
    PubMed    
    
    
    
62. MULLUR J, Buchheit KM
    Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
    Ann Allergy Asthma Immunol. 2023;131:317-324.
    PubMed     Abstract available
    
    
    
63. NAEGER S, Macina D, Pool V
    Tetanus, diphtheria, and acellular pertussis vaccine coverage in adults with chronic respiratory conditions.
    Ann Allergy Asthma Immunol. 2023;131:333-337.
    PubMed     Abstract available
    
    
    August 2023
64. SCHEPEL IRM, Banzon TM, Phipatanakul W
    Future of Biologics in Pediatric Asthma: Optimizing Response, Early Introduction, and Equitable Access to Treatment.
    Ann Allergy Asthma Immunol. 2023 Aug 29:S1081-1206(23)01207.
    PubMed     Abstract available
    
    
    
65. PERSAUD PN, Tran AP, Messner D, Thornton JD, et al
    Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.
    Ann Allergy Asthma Immunol. 2023 Aug 27:S1081-1206(23)00636.
    PubMed     Abstract available
    
    
    
66. SCELO G, Torres-Duque CA, Maspero J, Tran TN, et al
    Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
    Ann Allergy Asthma Immunol. 2023 Aug 26:S1081-1206(23)00630.
    PubMed     Abstract available
    
    
    
67. GALANT SP, Morphew T
    Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, potential targeted therapy.
    Ann Allergy Asthma Immunol. 2023 Aug 23:S1081-1206(23)00587.
    PubMed     Abstract available
    
    
    
68. PAVORD ID, Hoyte FCL, Lindsley AW, Ambrose CS, et al
    Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
    Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00593.
    PubMed     Abstract available
    
    
    
69. GAFFNEY A, Himmelstein DU, Woolhandler S
    Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US.
    Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00591.
    PubMed     Abstract available
    
    
    
70. HUI-BECKMAN J, Goleva E, Leung DYM, Kim BE, et al
    The impact of temperature on the skin barrier and atopic dermatitis.
    Ann Allergy Asthma Immunol. 2023 Aug 16:S1081-1206(23)00569.
    PubMed     Abstract available
    
    
    
71. WISNIVESKY JP, Agrawal N, Ankam J, Gonzalez A, et al
    World Trade Center Workers with Asthma and PTSD More Accurately Perceive Airflow Limitation.
    Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00568.
    PubMed     Abstract available
    
    
    
72. KAYSER MZ, Julicher BL, Welte T, Fuge J, et al
    Retrospective Analysis and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma.
    Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00567.
    PubMed    
    
    
    
73. AVDEEV SN, Gaynitdinova VV, Pozdnakova AA, Yu Chikina S, et al
    Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up.
    Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00564.
    PubMed    
    
    
    
74. HSU CS, Chen YM, Hsu CY, Deng YL, et al
    Diabetes Mellitus and Bone Mineral Density on Fracture Risk in Allergic Rhinitis and Asthma Patients.
    Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00565.
    PubMed    
    
    
    
75. KOENIGSBERG R, Grayson MH
    Did the coronavirus disease 2019 pandemic change asthma prevalence?
    Ann Allergy Asthma Immunol. 2023;131:141-142.
    PubMed    
    
    
    July 2023
76. CHAN R, Lipworth B
    Real life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2023 Jul 28:S1081-1206(23)00558.
    PubMed    
    
    
    
77. LEDFORD DK, Soong W, Carr W, Trevor J, et al
    Real-world Severe Asthma Biologic Administration and Adherence Differs by Biologic: CHRONICLE Study Results.
    Ann Allergy Asthma Immunol. 2023 Jul 26:S1081-1206(23)00522.
    PubMed     Abstract available
    
    
    
78. XIA T, Qiu H, Yu B, Bi J, et al
    Cost-Related Medication Nonadherence In U.S. Adults With Asthma: The National Health Interview Survey 2013-2020.
    Ann Allergy Asthma Immunol. 2023 Jul 25:S1081-1206(23)00518.
    PubMed     Abstract available
    
    
    
79. UGALDE IC, Ratigan A, Merriman C, Cui J, et al
    Preference for and Impact of Telehealth vs. In-person Asthma Visits Among Black and Latinx Adults.
    Ann Allergy Asthma Immunol. 2023 Jul 23:S1081-1206(23)00520.
    PubMed     Abstract available
    
    
    
80. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    An asthma phenotype comprising bronchial wall thickening and mucus plugging confers worse clinical outcomes.
    Ann Allergy Asthma Immunol. 2023 Jul 18:S1081-1206(23)00500.
    PubMed    
    
    
    
81. MOSNAIM G
    Can we improve adherence and asthma outcomes in children and adolescents with technology-based interventions?
    Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00493.
    PubMed    
    
    
    
82. ZAEH SE, Chupp G, Eakin MN
    Is there a Best Strategy to Prevent Asthma Exacerbations in Inner City Asthmatics?
    Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00492.
    PubMed    
    
    
    
83. LAU HX, Chen Z, Bever HV, Tham EH, et al
    Clinical predictors of wheeze trajectories and associations with allergy in Asian children.
    Ann Allergy Asthma Immunol. 2023 Jul 5:S1081-1206(23)00485.
    PubMed     Abstract available
    
    
    
84. SANTIAGO DVH, Fagbamigbe DAF, Sullivan PF, Agrawal DU, et al
    Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study.
    Ann Allergy Asthma Immunol. 2023 Jul 4:S1081-1206(23)00487.
    PubMed     Abstract available
    
    
    
85. BELLANTI JA, Schroer B, Marshall GD Jr, Grayson MH, et al
    The 80th anniversary of Annals of Allergy, Asthma & Immunology (1943-2023).
    Ann Allergy Asthma Immunol. 2023;131:128-130.
    PubMed     Abstract available
    
    
    
86. MENDOZA J, Carlson G, Nath P, Quinn J, et al
    A look at adherence with subcutaneous immunotherapy without out-of-pocket patient costs.
    Ann Allergy Asthma Immunol. 2023;131:96-100.
    PubMed     Abstract available
    
    
    June 2023
87. LANZ MJ, Gilbert IA, Gandhi HN, Pollack M, et al
    Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Jun 19:S1081-1206(23)00441.
    PubMed     Abstract available
    
    
    
88. LARENAS-LINNEMANN D, Romeo J, Ariue B, Oppenheimer J, et al
    ACAAI members' preferred step 1-3 asthma maintenance and reliever therapy and incomplete insurance coverage indicated as main practice hurdle.
    Ann Allergy Asthma Immunol. 2023 Jun 14:S1081-1206(23)00407.
    PubMed     Abstract available
    
    
    
89. KIM I, Morphew T, Chou C, Ehwerhemuepha L, et al
    Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children.
    Ann Allergy Asthma Immunol. 2023 Jun 13:S1081-1206(23)00417.
    PubMed    
    
    
    
90. LEE E, Rhee EH, Kim K, Kim HS, et al
    Frequency of exacerbation and degree of required asthma medication can characterize childhood longitudinal asthma trajectories.
    Ann Allergy Asthma Immunol. 2023 Jun 9:S1081-1206(23)00408.
    PubMed     Abstract available
    
    
    
91. NGUYEN AT, Settipane RA
    Erratum to "A potpourri of summer allergic environmental disorders" [Ann Allergy Asthma Immunol 130 (2023) 415-418].
    Ann Allergy Asthma Immunol. 2023;130:823.
    PubMed    
    
    
    May 2023
92. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00402.
    PubMed     Abstract available
    
    
    
93. EKSTEDT S, Lagebro V, Georen SK, Cardell LO, et al
    Prolonged inflammatory resolution in allergic asthma relates to dysfunctional interactions between neutrophils and airway epithelium.
    Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00400.
    PubMed     Abstract available
    
    
    
94. MENZIES-GOW A, Bourdin A, Chupp G, Israel E, et al
    Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: the NAVIGATOR study.
    Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00399.
    PubMed     Abstract available
    
    
    
95. DEBNATH C, Agarwal S, Atkinson C, Chong LK, et al
    Impact of Race on In-Hospital Outcomes of Patients Hospitalized for Asthma Exacerbation.
    Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00397.
    PubMed    
    
    
    
96. NAZARIO S, Gonzalez-Sepulveda L, Telon-Sosa B, Rivas-Tumanyan S, et al
    Place of death from asthma differs by age, race and ethnicity.
    Ann Allergy Asthma Immunol. 2023 May 22:S1081-1206(23)00359.
    PubMed    
    
    
    
97. WOO SD, Park HS, Jang JH, Lee Y, et al
    Biomarkers for Predicting Type 2-high and Uncontrolled Asthma in Real-World Practice.
    Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00339.
    PubMed     Abstract available
    
    
    
98. CHAN R, Lipworth B
    Clinical impact of obesity on oscillometry lung mechanics in adult asthmatics.
    Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00341.
    PubMed     Abstract available
    
    
    
99. BEDOLLA-BARAJAS M, Morales-Romero J, Robles-Figueroa M, Delgado-Figueroa T, et al
    Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study.
    Ann Allergy Asthma Immunol. 2023 May 2:S1081-1206(23)00327.
    PubMed     Abstract available
    
    
    
100. HANTGAN SL, Jariwala SP
     Erratum to "User-centered mobile health applications for asthma" [Ann Allergy Asthma Immunol 130 (2023) 159-160].
     Ann Allergy Asthma Immunol. 2023;130:692.
     PubMed    
     
     
     
101. GOLDSOBEL AB
     Corrigendum to "Chronic cough comes of age" [Ann Allergy Asthma Immunol 130 (2023) Pages 4-5].
     Ann Allergy Asthma Immunol. 2023;130:692.
     PubMed    
     
     
     
102. GALANT SP
     Could salivary alpha-amylase be a proxy for identifying beta-2 adrenergic induced tolerization in asthma?
     Ann Allergy Asthma Immunol. 2023;130:544-545.
     PubMed    
     
     
     
103. STROTHMAN K
     Choosing biologics for uncontrolled asthma: A conundrum for clinicians.
     Ann Allergy Asthma Immunol. 2023;130:534-535.
     PubMed    
     
     
     April 2023
104. LUCAS D, Gourier G, Bygvraa DA, Canals ML, et al
     Occupational allergic diseases among harvesting fishermen at the open sea: a systematic review.
     Ann Allergy Asthma Immunol. 2023 Apr 26:S1081-1206(23)00285.
     PubMed     Abstract available
     
     
     
105. CHIPPS B, Zeiger RS, Beuther DA, Reibman J, et al
     The Asthma Impairment and Risk Questionnaire Enhances the Assessment of Asthma Control.
     Ann Allergy Asthma Immunol. 2023 Apr 25:S1081-1206(23)00308.
     PubMed     Abstract available
     
     
     
106. SHEEHAN WJ, Maghzian N, Rastogi D, Bollard CM, et al
     Decreased Regulatory B Cells in Pediatric Patients with Asthma.
     Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00306.
     PubMed    
     
     
     
107. ITO K, Kanemitsu Y, Fukumitsu K, Tajiri T, et al
     Targeting the IL-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma.
     Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00310.
     PubMed     Abstract available
     
     
     
108. LEE JH, Hong C, Oh JS, Kim TB, et al
     Electronic Medical Record-Based Machine Learning Predicts the Relapse of Asthma Exacerbation.
     Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00307.
     PubMed    
     
     
     
109. HONG B, Merrill KA, Golding MA, Simons E, et al
     Pre-hospital epinephrine administration for treating anaphylaxis among those with co-morbid asthma: A scoping review.
     Ann Allergy Asthma Immunol. 2023 Apr 21:S1081-1206(23)00267.
     PubMed     Abstract available
     
     
     
110. SHANNON CM, Flaherty C, Quarshie WO, Xiao R, et al
     Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation.
     Ann Allergy Asthma Immunol. 2023 Apr 18:S1081-1206(23)00263.
     PubMed    
     
     
     
111. FUKUMITSU K, Kanemitsu Y, Kurokawa R, Takeda N, et al
     Tiotropium for refractory cough in asthma via cough reflex sensitivity: a randomized, parallel, open-label, trial.
     Ann Allergy Asthma Immunol. 2023 Apr 6:S1081-1206(23)00248.
     PubMed     Abstract available
     
     
     
112. TEAGUE WG
     Analysis of lung lavage granulocyte constituents and blood type 2 biomarkers does not support routine use of corticosteroids in children with problematic wheeze: Reply to: Short courses of oral corticosteroids are effective, important, and safe for vi
     Ann Allergy Asthma Immunol. 2023;130:526.
     PubMed    
     
     
     
113. WEINBERGER M
     Short courses of oral corticosteroids are effective, important, and safe for virus-triggered wheeze.
     Ann Allergy Asthma Immunol. 2023;130:525.
     PubMed    
     
     
     March 2023
114. LEE E, Park YM, Lee SY, Lee SH, et al
     Associations of prenatal antibiotic exposure and delivery mode on childhood asthma inception.
     Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00208.
     PubMed     Abstract available
     
     
     
115. REDDY A, Dunivin G, Garlapati R, Reddy S, et al
     Readability and quality of patient education material for asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00209.
     PubMed    
     
     
     
116. ALI H, Douwes J, Burmanje J, Gokhale P, et al
     Sputum inflammatory, neural, and remodelling mediators in eosinophilic and non-eosinophilic asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00181.
     PubMed     Abstract available
     
     
     
117. JACKSON DJ, Bacharier LB, Phipatanakul W, Sher L, et al
     Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00180.
     PubMed     Abstract available
     
     
     
118. HORN A, Bernstein DI, Okubo K, Dalgaard T, et al
     House Dust Mite Sublingual Immunotherapy Tablet Safety in Adolescents with Allergic Rhinoconjunctivitis: Clinical Trial Results.
     Ann Allergy Asthma Immunol. 2023 Mar 14:S1081-1206(23)00171.
     PubMed     Abstract available
     
     
     
119. CHIPPS BE, Soong W, Panettieri RA Jr, Carr W, et al
     Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma.
     Ann Allergy Asthma Immunol. 2023 Mar 9:S1081-1206(23)00165.
     PubMed     Abstract available
     
     
     
120. GUTWEIN A, Han YY, Colon-Semidey A, Alvarez M, et al
     Low parental numeracy and severe asthma exacerbations in a prospective study of Puerto Rican youth.
     Ann Allergy Asthma Immunol. 2023 Mar 7:S1081-1206(23)00166.
     PubMed     Abstract available
     
     
     
121. VOLERMAN A, Balachandran U, Zhu M, Akel M, et al
     Evaluating Inhaler Education Interventions for Hospitalized Children with Asthma: A Randomized Controlled Trial.
     Ann Allergy Asthma Immunol. 2023 Mar 2:S1081-1206(23)00131.
     PubMed     Abstract available
     
     
     
122. ACEVES SS, Dellon ES, Greenhawt M, Hirano I, et al
     Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick.
     Ann Allergy Asthma Immunol. 2023;130:371-378.
     PubMed     Abstract available
     
     
     February 2023
123. CHAN R, Lipworth B
     Efficacy of biologic therapy on airway hyperresponsiveness in asthma.
     Ann Allergy Asthma Immunol. 2023 Feb 23:S1081-1206(23)00121.
     PubMed     Abstract available
     
     
     
124. LEDFORD DK
     Self-Contained Underwater Breathing Apparatus (SCUBA) Diving and Asthma: Where are we in 2023?
     Ann Allergy Asthma Immunol. 2023 Feb 17:S1081-1206(23)00046.
     PubMed     Abstract available
     
     
     
125. STICKLER MB, Hamilton RG, Cooke RK, Bollinger ME, et al
     An emerging new respiratory pathogen, Lophomonas blattarum, found in bronchoalveolar lavage in an immunodeficient patient with asthma.
     Ann Allergy Asthma Immunol. 2023 Feb 13:S1081-1206(23)00091.
     PubMed    
     
     
     
126. KAMAN K, Dhodapkar M, Shabanova V, McCollum S, et al
     Validated Anxiety Assessments Among Pediatric Peanut-Allergic Patients on Oral Immunotherapy.
     Ann Allergy Asthma Immunol. 2023 Feb 2:S1081-1206(23)00080.
     PubMed     Abstract available
     
     
     
127. PANDYA A, Portnoy J
     Does improved indoor air quality lead to better asthma control?
     Ann Allergy Asthma Immunol. 2023;130:147-148.
     PubMed    
     
     
     
128. BORISH L, Teague WG, Patrie JT, Wavell KW, et al
     Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema.
     Ann Allergy Asthma Immunol. 2023 Feb 1:S1081-1206(23)00078.
     PubMed     Abstract available
     
     
     January 2023
129. HOLLENBACH JP, Collins MS, Wasser C, Fedele D, et al
     Implementation of standardized asthma management programs in outpatient settings.
     Ann Allergy Asthma Immunol. 2023 Jan 23:S1081-1206(23)00041.
     PubMed     Abstract available
     
     
     
130. OPPENHEIMER J, Borish L
     Operationalization of Dynamic Dosing in Asthma.
     Ann Allergy Asthma Immunol. 2023 Jan 17:S1081-1206(23)00008.
     PubMed    
     
     
     
131. SUZUKAWA M, Ohta K, Hashimoto H, Oyamada Y, et al
     Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan.
     Ann Allergy Asthma Immunol. 2023 Jan 16:S1081-1206(23)00005.
     PubMed     Abstract available
     
     
     
132. GALANT SP, Morphew T
     IN YOUNG ASTHMATIC CHILDREN, OBESITY AND UNCONTROLLED DISEASE ARE HIGHLY ASSOCIATED WITH PERIPHERAL AIRWAY IMPAIRMENT.
     Ann Allergy Asthma Immunol. 2023 Jan 13:S1081-1206(23)00004.
     PubMed     Abstract available
     
     
     
133. GOLDSOBEL AB
     Chronic cough comes of age.
     Ann Allergy Asthma Immunol. 2023;130:4-5.
     PubMed    
     
     
     
134. NEAVES BI, Adams KE, White KM, Stokes SC, et al
     Long-term adherence to imported fire ant subcutaneous immunotherapy.
     Ann Allergy Asthma Immunol. 2023;130:106-110.
     PubMed     Abstract available
     
     
     December 2022
135. PITRE T, Jassal T, Angjeli A, Jarabana V, et al
     A comparison of the effectiveness of biologic therapies for asthma:a systematic review and network meta-analysis.
     Ann Allergy Asthma Immunol. 2022 Dec 20:S1081-1206(22)02000.
     PubMed     Abstract available
     
     
     
136. CORBETT M, Allen A, Bobo N, Foggs MB, et al
     Proceedings of a Roundtable Conducted by the American College of Allergy, Asthma & Immunology on Racial Disparities in Atopic Dermatitis and Food Allergy.
     Ann Allergy Asthma Immunol. 2022 Dec 17:S1081-1206(22)02001.
     PubMed     Abstract available
     
     
     
137. CHEN JH, Orden T, Wang J, Sowho M, et al
     Risk of anaphylaxis in cluster versus standard subcutaneous multi-allergen immunotherapy.
     Ann Allergy Asthma Immunol. 2022 Dec 12:S1081-1206(22)01993.
     PubMed     Abstract available
     
     
     
138. CHAN R, Lipworth B
     Severe asthma with fungal sensitisation is associated with worse small airways dysfunction but similar symptom control.
     Ann Allergy Asthma Immunol. 2022 Dec 10:S1081-1206(22)01987.
     PubMed    
     
     
     
139. SHER LD, Passalacqua G, Taille C, Cohn L, et al
     Long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
     Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01983.
     PubMed     Abstract available
     
     
     
140. INSELMAN JW, Jeffery MM, Maddux JT, Lam RW, et al
     A prediction model for asthma exacerbations after stopping asthma biologics.
     Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01972.
     PubMed     Abstract available
     
     
     
141. CHAN R, Duraikannu C, Lipworth B
     Clinical characteristics of the asthma bronchiectasis phenotype.
     Ann Allergy Asthma Immunol. 2022 Dec 8:S1081-1206(22)01984.
     PubMed    
     
     
     
142. MAKIN T, Breidenbaugh M, Borish L
     Novel insights into pathogenic mechanisms of severe exacerbation-prone asthma and their impact on clinical management.
     Ann Allergy Asthma Immunol. 2022;129:651-652.
     PubMed    
     
     
     
143. GRAYSON MH
     Announcing the 2022 American College of Allergy, Asthma and Immunology Annals fellow-in-training award winners.
     Ann Allergy Asthma Immunol. 2022;129:649-650.
     PubMed    
     
     
     
144. TEAGUE WG
     Lung lavage inflammatory patterns and pathogen profiles in preschool children with problematic wheeze.
     Ann Allergy Asthma Immunol. 2022;129:674-675.
     PubMed    
     
     
     November 2022
145. KHAN DA
     The best of 2022 American College of Allergy, Asthma, and Immunology literature review.
     Ann Allergy Asthma Immunol. 2022 Nov 29:S1081-1206(22)01901.
     PubMed    
     
     
     
146. LI C, Zhang B, Yan M, Li Y, et al
     Cluster Analysis of Patients with Chronic Rhinosinusitis and Asthma after Endoscopic Sinus Surgery.
     Ann Allergy Asthma Immunol. 2022 Nov 24:S1081-1206(22)01955.
     PubMed     Abstract available
     
     
     
147. RIEDL MA
     Update on skin diseases: Urticaria, angioedema, and other skin disorders from the 2022 American College of Allergy, Asthma, and Immunology Annual Literature Review.
     Ann Allergy Asthma Immunol. 2022 Nov 23:S1081-1206(22)01913.
     PubMed    
     
     
     
148. HANTGAN SL, Jariwala SP
     User-centered mobile health applications for asthma.
     Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01917.
     PubMed    
     
     
     
149. ZHANG X, Xu Z, Lin J, Xie G, et al
     Sex differences of small airway function and FeNO in patients with mild asthma.
     Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01916.
     PubMed     Abstract available
     
     
     
150. BERGER P, Menzies-Gow A, Peters AT, Kuna P, et al
     Long-term efficacy of dupilumab in asthma with and without chronic rhinosinusitis and/or nasal polyps.
     Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01912.
     PubMed     Abstract available
     
     
     
151. GREINER B, Cronin K, Salazar L, Hartwell M, et al
     Asthma related disparities in emergency department usage and clinical outcomes among Spanish speaking Hispanic patients.
     Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01909.
     PubMed    
     
     
     
152. HANANIA NA, Castro M, Bateman E, Pavord ID, et al
     Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction.
     Ann Allergy Asthma Immunol. 2022 Nov 1. pii: S1081-1206(22)01899.
     PubMed     Abstract available
     
     
     
153. GHIASI Y, Wangberg H, Bagsic SRS, White A, et al
     Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2022;129:642-643.
     PubMed    
     
     
     October 2022
154. FONG WCG, Kadalayil L, Lowther S, Grevatt S, et al
     Efficacy of Dyson air purifier on asthma control: a single-center, investigator-led, randomized, double-blind, placebo-controlled trial.
     Ann Allergy Asthma Immunol. 2022 Oct 23. pii: S1081-1206(22)01850.
     PubMed     Abstract available
     
     
     
155. MCCULLOCH MR, Thomas JF, Thompson MA, Carel KD, et al
     Outpatient Electronic Consultations in Pediatric Allergy/Immunology.
     Ann Allergy Asthma Immunol. 2022 Oct 8. pii: S1081-1206(22)01827.
     PubMed    
     
     
     
156. LI JT
     Asthma chronic obstructive pulmonary disease and lower respiratory disorders.
     Ann Allergy Asthma Immunol. 2022 Oct 6:S1081-1206(22)01727.
     PubMed    
     
     
     
157. WEINBERGER M
     Can current hospitalization rates for asthma be decreased?
     Ann Allergy Asthma Immunol. 2022;129:401-402.
     PubMed    
     
     
     
158. WEINBERGER M
     Should asthma evaluation include assessment of small airway function?
     Ann Allergy Asthma Immunol. 2022;129:399-400.
     PubMed    
     
     
     
159. COLAK Y, Ingebrigtsen TS, Nordestgaard BG, Marott JL, et al
     Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
     Ann Allergy Asthma Immunol. 2022;129:490-496.
     PubMed     Abstract available
     
     
     September 2022
160. CHAN R, Stewart K, Lipworth B
     Airflow obstruction in real life is associated with small airways dysfunction in moderate to severe asthma.
     Ann Allergy Asthma Immunol. 2022 Sep 24. pii: S1081-1206(22)01775.
     PubMed    
     
     
     
161. SANGKANJANAVANICH S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, et al
     Bifidobacterium infantis 35624 Efficacy in Patients with Uncontrolled Asthma: A Randomized Placebo-Controlled Trial.
     Ann Allergy Asthma Immunol. 2022 Sep 8. pii: S1081-1206(22)01712.
     PubMed    
     
     
     August 2022
162. BIGGS SE, Ownby DR, May KR
     Use of over-the-counter inhaled epinephrine in asthma.
     Ann Allergy Asthma Immunol. 2022 Aug 27. pii: S1081-1206(22)01674.
     PubMed    
     
     
     
163. PRICE AS, Kennedy JL
     T helper 2 Mechanisms involved in Human Rhinovirus Infections and Asthma.
     Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00695.
     PubMed     Abstract available
     
     
     
164. LIU J, Yuan MB, Chen YQ, Wang Y, et al
     Global burden of asthma associated with high body mass index from 1990 to 2019.
     Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00694.
     PubMed     Abstract available
     
     
     
165. CHOW TG, Palka JM, Stone B, Trojan T, et al
     Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma.
     Ann Allergy Asthma Immunol. 2022 Aug 20. pii: S1081-1206(22)00693.
     PubMed     Abstract available
     
     
     
166. COLETTA C, Grayson MH
     Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic.
     Ann Allergy Asthma Immunol. 2022;129:131-132.
     PubMed    
     
     
     July 2022
167. BRYANT N, Muehling LM
     T-cell responses in asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Jul 30. pii: S1081-1206(22)00621.
     PubMed     Abstract available
     
     
     
168. IMAM SF, Zafar S, Oppenheimer J
     SMART in treatment of asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Jul 29. pii: S1081-1206(22)00619.
     PubMed     Abstract available
     
     
     
169. GREINER B, Hartwell M
     Prevalence and associations between metabolically unhealthy obesity and asthma exacerbations and emergency department usage.
     Ann Allergy Asthma Immunol. 2022 Jul 14. pii: S1081-1206(22)00590.
     PubMed     Abstract available
     
     
     
170. PATE CA, Zahran HS, Malilay J, Hsu J, et al
     The Shifting Prevalence of Asthma and Allergic Disease in United States Children.
     Ann Allergy Asthma Immunol. 2022 Jul 13. pii: S1081-1206(22)00586.
     PubMed     Abstract available
     
     
     June 2022
171. LEE TY, Petkau J, Mangat N, Safari A, et al
     16-year trends in asthma hospital admissions in Canada.
     Ann Allergy Asthma Immunol. 2022 Jun 29. pii: S1081-1206(22)00540.
     PubMed     Abstract available
     
     
     
172. DINWIDDIE DL, Kaukis N, Pham S, Hardin O, et al
     Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Jun 21. pii: S1081-1206(22)00535.
     PubMed     Abstract available
     
     
     
173. PANETTIERI RA JR, Ledford DK, Chipps BE, Soong W, et al
     Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists.
     Ann Allergy Asthma Immunol. 2022 Jun 18. pii: S1081-1206(22)00532.
     PubMed     Abstract available
     
     
     
174. POLIVKA BJ, Huntington-Moskos L, Antimisiaris DE, Cavallazzi RS, et al
     Phenotyping Older Adults with Asthma via Cluster Analysis.
     Ann Allergy Asthma Immunol. 2022 Jun 10. pii: S1081-1206(22)00501.
     PubMed    
     
     
     
175. RURAN HB, Maciag MC, Murphy SE, Phipatanakul W, et al
     Cross-Sectional Study of Urinary Biomarkers of Environmental Tobacco and E-Cigarette Exposure and Asthma Morbidity.
     Ann Allergy Asthma Immunol. 2022 Jun 7. pii: S1081-1206(22)00499.
     PubMed    
     
     
     
176. BELLANTI JA, Lanier BQ, Ein D, Finegold I, et al
     The American College of Allergy, Asthma & Immunology: an 80-year legacy of accomplishments (1942-2022), part 3: events and achievements (2012-2022).
     Ann Allergy Asthma Immunol. 2022 Jun 4. pii: S1081-1206(22)00494.
     PubMed    
     
     
     
177. CHUNG Y, Katial R, Mu F, Cook EE, et al
     Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
     Ann Allergy Asthma Immunol. 2022;128:669-676.
     PubMed     Abstract available
     
     
     May 2022
178. SCIOSCIA BG, Lacedonia D, Quarato CMI, Tondo P, et al
     Could Transthoracic Ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma?
     Ann Allergy Asthma Immunol. 2022 May 25. pii: S1081-1206(22)00491.
     PubMed     Abstract available
     
     
     
179. CHUPP G, Wechsler ME
     Biologic Medications in Asthma: What have we learned from long-term studies?
     Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00489.
     PubMed    
     
     
     
180. WANG EA, Goleva E, Ketosugbo K, Kern JA, et al
     Effect of immune checkpoint inhibitors on asthma.
     Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00487.
     PubMed    
     
     
     
181. LIPWORTH DB, Stewart MK, Chan DR
     Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
     Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.
     PubMed    
     
     
     
182. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
     Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
     Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.
     PubMed    
     
     
     
183. SHERREY J, Biggs S, Dorrian J, Martin J, et al
     Allergic disease, sleep problems and psychological distress in children recruited from the general community.
     Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00409.
     PubMed     Abstract available
     
     
     
184. MENDY A, Mersha TB
     Comorbidities in Childhood-onset and Adult-Onset Asthma.
     Ann Allergy Asthma Immunol. 2022 May 17. pii: S1081-1206(22)00410.
     PubMed     Abstract available
     
     
     
185. POLINSKI KJ, Bell GA, Trinh MH, Sundaram R, et al
     Maternal obesity, gestational weight gain and offspring asthma and atopy.
     Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00397.
     PubMed     Abstract available
     
     
     
186. WILSON K, Gebretsadik T, Adgent MA, Loftus C, et al
     The association between duration of breastfeeding and childhood asthma outcomes.
     Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00400.
     PubMed     Abstract available
     
     
     
187. YAMANE M, Ohnishi H, Tsuji K, Anabuki K, et al
     Dupilumab-induced peripheral neuropathy in a patient with severe asthma.
     Ann Allergy Asthma Immunol. 2022;128:611.
     PubMed    
     
     
     
188. GALANT SP, Morphew T, Ehwerhemuepha L
     Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.
     Ann Allergy Asthma Immunol. 2022;128:486-487.
     PubMed    
     
     
     
189. WHITE AA
     If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
     Ann Allergy Asthma Immunol. 2022;128:484-485.
     PubMed    
     
     
     
190. GRAYSON MH
     New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program.
     Ann Allergy Asthma Immunol. 2022;128:483.
     PubMed    
     
     
     
191. SPERGEL BL, Ruffner MA, Godwin BC, Liacouras CA, et al
     Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
     Ann Allergy Asthma Immunol. 2022;128:589-593.
     PubMed     Abstract available
     
     
     April 2022
192. HASAN ARSHAD S
     Does allergen Immunotherapy for allergic rhinitis prevent asthma?
     Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00392.
     PubMed     Abstract available
     
     
     
193. WONG M, Forno E, Celedon JC
     Asthma: interactions between obesity and other risk factors.
     Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00394.
     PubMed     Abstract available
     
     
     
194. NIESSEN NM, Fricker M, McDonald VM, Gibson PG, et al
     T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma.
     Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00342.
     PubMed     Abstract available
     
     
     
195. CIPRANDI G, Schiavetti I, Cioffi L, Pane M, et al
     The PRObiotics in Pediatric Asthma Management (PROPAM) study: a post-hoc analysis in allergic children.
     Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00391.
     PubMed    
     
     
     
196. ELDEIRAWI KM, Nyenhuis SM, Huntington-Moskos L, Polivka BJ, et al
     COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults.
     Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00308.
     PubMed    
     
     
     
197. WINSLOW A, Keet C
     Preventing Allergies Through the Skin.
     Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00311.
     PubMed     Abstract available
     
     
     
198. ZHANG H, Xian M, Shi X, Luo T, et al
     Blocking function of allergen-specific IgG, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy.
     Ann Allergy Asthma Immunol. 2022 Apr 8. pii: S1081-1206(22)00293.
     PubMed     Abstract available
     
     
     
199. ALABDULKARIM N, Gai J, Bost J, Pillai D, et al
     Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation.
     Ann Allergy Asthma Immunol. 2022 Apr 7. pii: S1081-1206(22)00294.
     PubMed     Abstract available
     
     
     
200. CROPPER KJ, Davis BE, Cockcroft DW
     Effect of daily tiotropium on allergen-induced early asthmatic responses and airway inflammation.
     Ann Allergy Asthma Immunol. 2022 Apr 5. pii: S1081-1206(22)00296.
     PubMed    
     
     
     
201. OPPENHEIMER J, Leung DYM
     Asthma 2022-moving toward precision medicine.
     Ann Allergy Asthma Immunol. 2022;128:343.
     PubMed    
     
     
     
202. BORISH L
     Rethinking the central role of mast cells in virally-mediated asthma exacerbations.
     Ann Allergy Asthma Immunol. 2022 Apr 1. pii: S1081-1206(22)00288.
     PubMed    
     
     
     
203. MISS OZUNA L, Ryan T, Bensko JC, Laidlaw TM, et al
     Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2022;128:469-472.
     PubMed    
     
     
     March 2022
204. HOWELL D, Rogers L, Kasarskis A, Twyman K, et al
     Comparison and Validation of Algorithms for Asthma Diagnosis in an Electronic Medical Record System.
     Ann Allergy Asthma Immunol. 2022 Mar 30. pii: S1081-1206(22)00285.
     PubMed     Abstract available
     
     
     
205. MACDONALD M, Chang WC, Martin LJ, Hershey GKK, et al
     The Pediatric Asthma Risk Score (PARS): more does not mean better.
     Ann Allergy Asthma Immunol. 2022 Mar 29. pii: S1081-1206(22)00284.
     PubMed    
     
     
     
206. KIMURA H, Shimizu K, Tanabe N, Makita H, et al
     Further evidence for association of YKL-40 with severe asthma airway remodeling.
     Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00207.
     PubMed     Abstract available
     
     
     
207. LUDWIG A, Brehm C, Fung C, Jia S, et al
     Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience.
     Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00208.
     PubMed     Abstract available
     
     
     
208. OPPENHEIMER J, Hoyte FCL, Phipatanakul W, Silver J, et al
     Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions.
     Ann Allergy Asthma Immunol. 2022 Mar 7. pii: S1081-1206(22)00170.
     PubMed     Abstract available
     
     
     
209. ADEJUMO I, Patel M, McKeever TM, Shaw DE, et al
     Does inhaler technology improve adherence and asthma control? A pilot randomised controlled trial.
     Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00169.
     PubMed    
     
     
     
210. WANG Y, Guo D, Chen X, Wang S, et al
     Trends in asthma among adults in the United States, NHANES 2005-2018.
     Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00168.
     PubMed    
     
     
     
211. PATEL P, Bensko JC, Bhattacharyya N, Laidlaw TM, et al
     Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
     Ann Allergy Asthma Immunol. 2022;128:326-328.
     PubMed    
     
     
     February 2022
212. KOINIS-MITCHELL D, D'Angelo C, Dunsiger S, McQuaid E, et al
     Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping.
     Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00120.
     PubMed     Abstract available
     
     
     
213. MACIAG MC, Phipatanakul W
     Update on Indoor Allergens and Their Impact on Pediatric Asthma.
     Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00119.
     PubMed     Abstract available
     
     
     
214. RAMEY OL, Silva Almodovar A, Nahata MC
     Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic.
     Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00121.
     PubMed     Abstract available
     
     
     
215. MELHORN DJ, Howell DI, Pavord PID
     Should we apply a treatable traits approach to asthma care?
     Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00098.
     PubMed     Abstract available
     
     
     
216. SEHAYEK D, Gold MS, Gabrielli S, Abrams EM, et al
     Seafood-Induced Anaphylaxis in Children Presenting to Canadian Emergency Departments: Rates, Clinical Presentation and Management.
     Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00097.
     PubMed     Abstract available
     
     
     
217. ENG V, Moreno GP, Chang J, Liebhaber M, et al
     A Pediatric Asthma Camp Experience during the COVID-19 Pandemic.
     Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00087.
     PubMed    
     
     
     
218. MULLUR J, Steger CM, Gakpo D, Bensko JC, et al
     Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
     Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00090.
     PubMed     Abstract available
     
     
     
219. CHIPPS BE, Murphy KR, Wise RA, McCann WA, et al
     Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall.
     Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00081.
     PubMed     Abstract available
     
     
     
220. GUILBERT TW, Biagini JM, Ramsey RR, Keidel K, et al
     Treatment by Biomarker-Informed Endotype Versus Guideline Care in Children with Difficult to Treat Asthma.
     Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00076.
     PubMed    
     
     
     January 2022
221. STOUT S, Murphy H, Pandya A, Yeh HW, et al
     The Effect of COVID-19 on Asthma Visits.
     Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00048.
     PubMed    
     
     
     
222. GENG B, Dixon AE, Ko J, Janampally P, et al
     Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
     Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00045.
     PubMed     Abstract available
     
     
     
223. WANG E, Wechsler ME
     A Rational Approach to Compare and Select Biologic Therapeutics in Asthma.
     Ann Allergy Asthma Immunol. 2022 Jan 27. pii: S1081-1206(22)00046.
     PubMed     Abstract available
     
     
     
224. POPOV TA, Hristova D, Kralimarkova TZ, Mustakov TB, et al
     Time course of disease characteristics in subjects with severe allergic asthma starting treatment with omalizumab.
     Ann Allergy Asthma Immunol. 2022 Jan 24. pii: S1081-1206(22)00024.
     PubMed    
     
     
     
225. DROUIN O, Smyrnova A, Betinjane N, Ducharme FM, et al
     Adherence to inhaled corticosteroids prescribed once- vs twice-daily in children with asthma.
     Ann Allergy Asthma Immunol. 2022 Jan 22. pii: S1081-1206(22)00022.
     PubMed     Abstract available
     
     
     
226. MUISER S, Gosens R, van den Berge M, Kerstjens HAM, et al
     Understanding the role of long-acting muscarinic antagonists in asthma treatment.
     Ann Allergy Asthma Immunol. 2022 Jan 21. pii: S1081-1206(22)00017.
     PubMed     Abstract available
     
     
     
227. ESCHENBACHER W, Kim M, Mattos J, Lawrence M, et al
     Activation of platelet-adherent basophils in chronic rhinosinusitis with alcohol hypersensitivity.
     Ann Allergy Asthma Immunol. 2022 Jan 18. pii: S1081-1206(22)00014.
     PubMed     Abstract available
     
     
     
228. FENG X, Lawrence MG, Payne SC, Mattos J, et al
     Lower viral loads in rhinovirus-challenged allergic subjects despite reduced innate immunity.
     Ann Allergy Asthma Immunol. 2022 Jan 12. pii: S1081-1206(22)00010.
     PubMed     Abstract available
     
     
     
229. VISWAM D, Mansur AH
     Mode of onset and triggers of severe asthma; the severe asthma clinic perspective.
     Ann Allergy Asthma Immunol. 2022 Jan 11. pii: S1081-1206(22)00008.
     PubMed    
     
     
     
230. WONG M, Han YY, Rosser F, Acosta-Perez E, et al
     Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican Youth.
     Ann Allergy Asthma Immunol. 2022 Jan 8. pii: S1081-1206(22)00005.
     PubMed     Abstract available
     
     
     
231. LOBATO M, Gaspar-Marques J, Carreiro-Martins P, Pinto PL, et al
     Secondary adrenal suppression related to high doses of inhaled corticosteroids in severe asthma patients.
     Ann Allergy Asthma Immunol. 2022 Jan 7. pii: S1081-1206(22)00002.
     PubMed    
     
     
     
232. BACHARIER LB
     Asthma Guidelines: Where to next?: A Perspective for Annals of Allergy, Asthma & Immunology.
     Ann Allergy Asthma Immunol. 2022 Jan 5. pii: S1081-1206(21)01342.
     PubMed    
     
     
     
233. WANG E, Zahid S, Moudgal AN, Demaestri S, et al
     Intimate Partner Violence and Asthma in Pediatric and Adult Populations: A Systematic Review.
     Ann Allergy Asthma Immunol. 2022 Jan 4. pii: S1081-1206(21)01343.
     PubMed     Abstract available
     
     
     
234. LAWRENCE MG, Teague WG, Feng X, Welch C, et al
     Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils.
     Ann Allergy Asthma Immunol. 2022;128:53-60.
     PubMed     Abstract available
     
     
     December 2021
235. BURROWS AG, Ellis AK
     Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy.
     Ann Allergy Asthma Immunol. 2021 Dec 28. pii: S1081-1206(21)01310.
     PubMed    
     
     
     
236. FISCHELL SZ, Fischell JM, Olexa G, Callahan C, et al
     Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population.
     Ann Allergy Asthma Immunol. 2021 Dec 16. pii: S1081-1206(21)01308.
     PubMed    
     
     
     November 2021
237. CORREN J, Silver J, Molfino NA, Bogart M, et al
     A real-world study of ICS use in patients with severe eosinophilic asthma treated with mepolizumab.
     Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01219.
     PubMed     Abstract available
     
     
     
238. LU MA, Eckmann T, Ruvalcaba E, McQuaid EL, et al
     Family Management of Asthma in Head Start Preschool Children.
     Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01217.
     PubMed     Abstract available
     
     
     
239. CARR TF
     Treatment approaches for the patient with T2 low asthma.
     Ann Allergy Asthma Immunol. 2021;127:530-535.
     PubMed     Abstract available
     
     
     
240. OPPENHEIMER JJ, Leung DYM
     Asthma, in quest of optimizing care.
     Ann Allergy Asthma Immunol. 2021;127:517.
     PubMed    
     
     
     
241. LEVERONE N, Tran S, Barry J, Akuthota P, et al
     Diagnoses associated with peripheral blood eosinophilia: A 5-year review.
     Ann Allergy Asthma Immunol. 2021;127:597-598.
     PubMed    
     
     
     October 2021
242. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
     Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
     Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
     PubMed     Abstract available
     
     
     
243. GRANT T, Croce E, Matsui E
     Asthma and the Social Determinants of Health.
     Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
     PubMed     Abstract available
     
     
     
244. AVDEEV SN, Pozdnakova AA, Gaynitdinova VV, Chikina SY, et al
     Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality.
     Ann Allergy Asthma Immunol. 2021 Oct 17. pii: S1081-1206(21)01163.
     PubMed    
     
     
     
245. HOSSAIN R, Zhao F, Michenkova M, Kaelber D, et al
     Trends in racial disparities in asthma emergency department utilization during COVID-19.
     Ann Allergy Asthma Immunol. 2021 Oct 12. pii: S1081-1206(21)01159.
     PubMed    
     
     
     
246. TORRE AB, Dasgupta R, Eldeirawi KM, Nyenhuis SM, et al
     Positive associations of pollutants and aeroallergens with allergic rhinitis in adults with asthma.
     Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01157.
     PubMed    
     
     
     
247. STAMPFLI M, Frei R, Divaret-Chauveau A, Schmausser-Hechfellner E, et al
     Inverse associations between food diversity in the 2(nd) year of life and allergic diseases.
     Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01154.
     PubMed     Abstract available
     
     
     
248. BLEECKER ER, Gandhi H, Gilbert I, Murphy KR, et al
     Mapping Geographic Variability of Severe Uncontrolled Asthma in the United States: Management Implications.
     Ann Allergy Asthma Immunol. 2021 Oct 7. pii: S1081-1206(21)01125.
     PubMed     Abstract available
     
     
     September 2021
249. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
     National decline in asthma exacerbations in US during COVID19 pandemic.
     Ann Allergy Asthma Immunol. 2021 Sep 25. pii: S1081-1206(21)01113.
     PubMed    
     
     
     
250. SACO T, Ugalde IC, Cardet JC, Casale TB, et al
     Strategies for choosing a biologic for your patient with allergy or asthma.
     Ann Allergy Asthma Immunol. 2021 Sep 23. pii: S1081-1206(21)01035.
     PubMed     Abstract available
     
     
     July 2021
251. BALL L, Velasquez SA, Jammal OMA, White AA, et al
     Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
     Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.
     PubMed    
     
     
     
252. UDOKO M, De Keyser H, Szefler SJ
     Should Asthmatic Children Simply be Treated as Little Adults?
     Ann Allergy Asthma Immunol. 2021 Jul 11. pii: S1081-1206(21)00498.
     PubMed    
     
     
     
253. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
     From the Pages of Allergy Watch.
     Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.
     PubMed    
     
     
     May 2021
254. ABRAMS EM, Greenhawt M, Shaker M, Kosowan L, et al
     Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada.
     Ann Allergy Asthma Immunol. 2021 May 15. pii: S1081-1206(21)00357.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.